¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"plasma component transfusion"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • direct transfusion
    Á÷Á¢¼öÇ÷
  • exchange transfusion
    ±³È¯¼öÇ÷
  • febrile transfusion reaction
    ¹ß¿­¼º¼öÇ÷¹ÝÀÀ
  • fetomaternal transfusion
    žƸðü¼öÇ÷
  • fetus to fetus transfusion
    žƻçÀ̼öÇ÷
  • hemolytic transfusion reaction
    ¿ëÇ÷¼º¼öÇ÷¹ÝÀÀ
  • immediate transfusion
    Áï½Ã¼öÇ÷, ¹Ù·Î¼öÇ÷
  • incompatible blood transfusion
    ºÎÀûÇÕ¼öÇ÷
  • intramedullary transfusion
    °ñ¼ö¼Ó¼öÇ÷, °ñ¼ö³»¼öÇ÷
  • massive transfusion
    ´ë·®¼öÇ÷
  • nonimmunologic febrile transfusion reaction
    ºñ¸é¿ª¹ß¿­¼º¼öÇ÷¹ÝÀÀ
  • nonimmunologic hemolytic transfusion reaction
    ºñ¸é¿ª¿ëÇ÷¼º¼öÇ÷¹ÝÀÀ
  • nonimmunologic nonhemolytic transfusion reaction
    ºñ¸é¿ªºñ¿ëÇ÷¼º¼öÇ÷¹ÝÀÀ
  • placental transfusion syndrome
    ŹݼöÇ÷ÁõÈıº
  • post-transfusion hepatitis
    ¼öÇ÷Èİ£¿°
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 4 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • feto-maternal transfusion
    žƸðü¼öÇ÷
  • fetus to fetus transfusion
    ½ÖžƻçÀ̼öÇ÷
  • massive transfusion
    ´ë·®¼öÇ÷
  • substitution transfusion
    (¢¡exchange transfusion) ±³È¯¼öÇ÷
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • bone marrow transfusion
    °ñ¼ö¼öÇ÷
  • cryoprecipitate transfusion
    µ¿°áħÀüÁ¦Á¦¼öÇ÷
  • delayed hemolytic transfusion reaction
    Áö¿¬¿ëÇ÷¼öÇ÷ºÎÀÛ¿ë
  • direct transfusion
    (¢¡immediate transfusion) Áï½Ã¼öÇ÷, ¹Ù·Î¼öÇ÷
  • exchange transfusion
    ±³È¯¼öÇ÷
  • exsanguination transfusion
    (¢¡exchange transfusion) ±³È¯¼öÇ÷
  • febrile transfusion reaction
    ¹ß¿­¼öÇ÷ºÎÀÛ¿ë
  • hemolytic transfusion reaction
    ¿ëÇ÷¼öÇ÷¹ÝÀÀ
  • post-transfusion hepatitis
    ¼öÇ÷Èİ£¿°
  • transfusion hepatitis
    (¢¡post-transfusion hepatitis) ¼öÇ÷Èİ£¿°
  • immediate transfusion
    Áï½Ã¼öÇ÷, ¹Ù·Î¼öÇ÷
  • incompatible blood transfusion
    ºÎÀûÇÕ¼öÇ÷
  • indirect transfusion
    °£Á¢¼öÇ÷
  • transfusion-transmitted infection
    ¼öÇ÷ÀüÆÄ°¨¿°
  • massive transfusion
    ´ë·®¼öÇ÷
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • platelet transfusion
    Ç÷¼ÒÆÇ¼öÇ÷
  • post transfusion hepatitis
    ¼öÇ÷Èİ£¿°.
  • post transfusion purpura
    ¼öÇ÷ÈÄÀÚ¹ÝÁõ(âÃúìý­í¹Úèñø)
  • post-transfusion thrombocytopenia
    ¼öÇ÷ÈÄÇ÷¼ÒÆÇ°¨¼ÒÁõ
  • pre-transfusion testing
    ¼öÇ÷Àü°Ë»ç
  • ERPF => effective renal plasma flow
    À¯È¿½ÅÇ÷ÀåÀ¯Åë·®
  • ERPF=£¾effective renal plasma flow
    À¯È¿½ÅÇ÷·ù·®.
  • RPF => renal plasma flow
    ½ÅÇ÷Àå·ù(·®)
  • RPR test => rapid plasma reagin test
    ½Å¼ÓÇ÷À帮¾ÆÁø<°¨ÀÛÇ×ü>½ÃÇè
  • antihemophilic plasma
    Ç×Ç÷¿ìº´Ç÷Àå (¡­úìíì).
  • antihemophilic plasma
    Ç×Ç÷¿ìº´Ç÷Àå (?Ì´Ëö).
  • fresh frozen plasma=FFP
    ½Å¼±µ¿°áÇ÷Àå
  • plasma
    Ç÷Àå(úìíì), ÇöóÁ.
  • plasma
    Ç÷Àå
  • plasma analysis
    Ç÷ÀåºÐ¼®
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • principal component
    ÁÖ¼ººÐ(ñ«à÷ÝÂ).
  • quick component
    ±Þ°Ý¼ººÐ(ÐáÌ­à÷ÝÂ).
  • secretory component
    ºÐºñ¼ººÐ
  • series elastic component
    Á÷·Äź·Â¼ººÐ(òÁ æê÷¥æ³à÷ÝÂ).
  • slow component
    ¿Ï¼­¼ººÐ(èÐßïà÷ÝÂ).
  • third component
    Á¦»ï¼ººÐ(ð¯ß²à÷ÝÂ).
  • acute hemolytic transfusion reaction
    ±Þ¼º¿ëÇ÷¼º¼öÇ÷¹ÝÀÀ
  • autologous transfusion
    ÀÚ°¡¼öÇ÷(¹ý).
  • autologous transfusion
    ÀÚ°¡¼öÇ÷
  • blood transfusion
    ¼öÇ÷
  • blood transfusion
    ¼öÇ÷(¼öÇ÷).
  • blood transfusion
    ¼öÇ÷(âÃúì)
  • blood transfusion reaction
    ¼öÇ÷ºÎÀÛ¿ë.
  • bone marrow transfusion
    °ñ¼öÀ̽Ä(¼ú)(?ËöËàËà).
  • bone marrow transfusion
    °ñ¼ö¼öÇ÷.
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 13 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • plasma membrane
    ¿øÇüÁú¸·(ê«û¡òõد)
  • plasma proteins
    Ç÷Àå ´Ü¹éÁú(úìíìÓ±ÛÜòõ)
  • plasma sol
    Á¹»ó(ßÓ) ¿øÇüÁú(ê«û¡òõ)
  • plasma-specific enzyme
    Ç÷À寝ÀÌ È¿¼Ò(úìíì÷åì¶ý£áÈ)
  • plasma thromboplastic factor
    Ç÷Àå Ç÷ÀüÇü¼ºÀÎÀÚ(úìíìúìîûû¡à÷ì×í­)
  • plasma thromboplastic factor B
    Ç÷Àå Ç÷ÀüÇü¼ºÀÎÀÚ B
  • plasma thromboplastin antecedent
    Ç÷Àå(úìíì) Æ®·Òº¸ÇÃ¶ó½ºÆ¾ Àü±¸¹°(îñÏÌÚª)
  • plasma transferrin
    Ç÷Àå(úìíì) Æ®¶õ½ºÆä¸°
  • plasma transglutaminase
    Ç÷Àå(úìíì) Æ®¶õ½º±Û·çŸ¹Ì³×À̽º
  • separated plasma
    ºÐ¸®Ç÷Àå(ÝÂ×îúìíì)
  • sex steroid binding plasma protein
    ¼º(àõ)½ºÅ×·ÎÀÌµå °áÇÕ(Ì¿ùê) Ç÷Àå(úìíì) ´Ü¹éÁú(úìíìÓ±ÛÜòõ)
  • true plasma
    ¼øÇ÷Àå(âíúìíì)
  • whole plasma
    ÀüÇ÷Àå(îïúìíì)
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
PTR patellar tendon reflex; patient termination record; patient to return; peripheral total resistance; ...
PTC   1) Percutaneous Transhepatic Cholangiography
    = PTHC
 ...
SAP Serum Amyloid Plasma component
PTC papillary thyroid carcinoma; percutaneous transhepatic cholangiography; phase transfer catalyst; phe...
PTH parathormone; parathyroid; parathyroid hormone; percutaneous transhepatic drainage; phenylthiohydant...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
ET Exchange transfusion
HTR Hemolytic transfusion reactions
IUT Intrauterine transfusion
PTP Post transfusion purpura
PT-GVHD Post-transfusion graft-versus-host disease
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • exchange transfusion
    ±³È¯ ¼öÇ÷
    ȯÀÚÀÇ ÀüÇ÷¾×À» °øÇ÷ÀÚÀÇ Ç÷¾×À¸·Î ġȯÇÏ´Â ¹æ¹ýÀÌ¸ç ½Å»ý¾ÆÀÇ ¿ëÇ÷¼º ºóÇ÷ µî¿¡ »ç¿ëµÈ´Ù.
  • immediate transfusion
    Á÷Á¢ ¼öÇ÷, Áï°¢ ¼öÇ÷, Áï½Ã ¼öÇ÷
    Áß°£ ¿ë±â³ª Ç×ÀÀ°íÁ¦¸¦ »ç¿ëÇÏÁö ¾Ê°í, ¾î¶² »ç¶÷À¸·ÎºÎÅÍ ´Ù¸¥ »ç¶÷¿¡°Ô·Î Ç÷¾×À» Á÷Á¢ ¿Å±â´Â °Í.
  • incompatible blood transfusion
    ºÎÀûÇÕ ¼öÇ÷
  • malaria transfusion
    ¼öÇ÷ ¸»¶ó¸®¾Æ
    ¿À¿°µÈ ÁÖ»ç ¹Ù´ÃÀÇ ¿ì¹ßÀû °¨¿°À̳ª, ÁÖ»ç ¹Ù´ÃÀ» °øµ¿À¸·Î »ç¿ëÇÏ´Â ¾à¹° Ž´ÐÀÚ¿¡ ÀÇÇØ¼­ °øÇ÷ÀڷκÎÅÍ Á÷Á¢ ÀüÆÄµÇ´Â Plasmodium malariae, Plasmodium vivax, Plasmodium ovaleÀÇ °¨¿°.
  • platelet transfusion
    Ç÷¼ÒÆÇ ¼öÇ÷
  • post-transfusion thrombocytopenia
    ¼öÇ÷ÈÄ Ç÷¼ÒÆÇ °¨¼ÒÁõ
  • serum transfusion
    Ç÷û ¼öÇ÷
  • transfusion
    ¼öÇ÷, ¼ö¾×
    ÀüÇ÷À̳ª Ç÷¾× ¼ººÐÀÌ Ç÷·ù·Î Á÷Á¢ µé¾î°¡´Â °Í.
  • transfusion procedure
    ¼öÇ÷ óġ
  • white blood cell transfusion
    ¹éÇ÷±¸ ¼öÇ÷
  • whole blood transfusion
    ÀüÇ÷ ¼öÇ÷
  • blood plasma substitute
    ´ë¿ë Ç÷Àå
  • citrated normal human plasma
    Á¤»óÀÎ ±¸¿¬»ê¿° ÷°¡ Ç÷Àå
  • malignant plasma cell
    ¾Ç¼º ÇüÁú ¼¼Æ÷
  • pathologic plasma protein
    º´Àû Ç÷Àå ´Ü¹é
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
secretory component <physiology> A glycoprotein found in a variety of external secretions (tears, bile, colostrum) usually complexed to secreted polymeric immunoglobulins (IgA or, less frequently IgM).
It is derived, by proteolytic cleavage, from the polymeric immunoglobulin receptor (receptors, polymeric immunoglobulin) and probably functions to protect the immunoglobulins from proteolysis in the secretions.
(12 Dec 1998)
secretory component of IgA <immunology, protein> A polypeptide chain of about 60 kD that aids secretion of the IgA, a portion of the IgA receptor on the plasmalemma of the inner side of the epithelial cells lining the gut, which is proteolysed when the IgA receptor complex has travelled through the cell after receptor mediated endocytosis at the inner face, to the outer (luminal) face.
(18 Nov 1997)
serum amyloid P component Precursor of amyloid component P, found in basement membrane. Member of the pentraxin family.
See: serum amyloid.
(18 Nov 1997)
fast component <molecular biology> A segment of eukaryotic DNA consisting of highly-repeated nucleotide sequences which, when the entire duplex DNA molecule is denatured (the double-stranded helix comes apart and becomes single strands) and then allowed to renature (the complementary single strands come together to form a helix), will be the first segment to renature.
(09 Oct 1997)
arterial transfusion Direct transfusion from an artery of the donor into an artery of the receptor.
(05 Mar 2000)
blood transfusion The process of infusing blood products into a patient to raise the individuals concentration of red blood cells. Blood is typed (A, B, O or AB) and crossmatched (mixed together to see if its compatible) prior to transfusion.
(27 Sep 1997)
blood transfusion, autologous Reinfusion of blood or blood products derived from the patient's own circulation.
(12 Dec 1998)
blood transfusion, intrauterine Transfusion of rh-negative blood into the peritoneal cavity of an unborn infant in the treatment of foetal erythroblastosis (erythroblastosis, foetal) in utero.
(12 Dec 1998)
blood transfusion reaction This refers to an immune response against transfused blood cells. Antigens, on the surface of red blood cells, are recognised as foreign proteins and can stimulate sensitised lymphocytes to produce antibodies to the red blood cell antigens. This triggers a complex immunological reaction that results in the destruction of the transfused red blood cell. The blood groups (A, B, AB, O) are classified on the basis of the presence of surface antigens on the red blood cell. Type A blood has A antigens. The plasma component of the blood contains the antibodies against all other blood group antigens other that its own. Another type of surface antigen is known as Rh factor. Rh factor is either present (Rh positive) or absent (Rh negative). Rh compatibility is another requirement for blood transfusion.
Symptoms and findings of a transfusion reaction include flank pain, fever, chills, bloody urine, rash, low blood pressure, dizziness and fainting.
(27 Sep 1997)
reciprocal transfusion An attempt to confer immunity by transfusing blood taken from a donor into a receiver suffering from the same affection, the balance being maintained by transfusing an equal amount from the receiver to the donor.
(05 Mar 2000)
mediate transfusion Transfusion into a patient of blood previously obtained from a donor and stored in a suitable container.
Synonym: mediate transfusion.
(05 Mar 2000)
peritoneal transfusion The injection of saline solution or other fluid into the peritoneal cavity.
(05 Mar 2000)
placental transfusion Return to the newborn via the umbilical vessels some of the foetal placental blood.
(05 Mar 2000)
platelet transfusion The transfer of blood platelets from a donor to a recipient or reinfusion to the donor.
(12 Dec 1998)
subcutaneous transfusion An infusion of absorbable solutions beneath the skin.
(05 Mar 2000)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
ÅëÇÕ°Ë»ö ¿Ï·á